SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-042710
Filing Date
2023-04-06
Accepted
2023-04-06 16:24:08
Documents
12
Period of Report
2023-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2311951d1_8k.htm   iXBRL 8-K 22829
  Complete submission text file 0001104659-23-042710.txt   193713

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ocul-20230331.xsd EX-101.SCH 3024
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocul-20230331_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocul-20230331_pre.xml EX-101.PRE 22589
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2311951d1_8k_htm.xml XML 3491
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36554 | Film No.: 23806486
SIC: 2834 Pharmaceutical Preparations